Remoxipride, a new selective D2 antagonist, and haloperidol in cebus monkeys
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 14 (1) , 103-112
- https://doi.org/10.1016/0278-5846(90)90068-r
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Tardive dyskinesia may be due to an increase d1/d2 receptor ratio in the brain : Jes Gerlach and Henrik Lublin Sct Hans Hospital, Department 2 and Psychopharmacological Laboratory, Roskilde, DenmarkSchizophrenia Research, 1988
- Tardive dyskinesiaActa Psychiatrica Scandinavica, 1988
- Relative Dopamine D1and D2Receptor Affinity and Efficacy Determine Whether Dopamine Agonists Induce Hyperactivity or Oral Stereotypy in RatsBasic & Clinical Pharmacology & Toxicology, 1988
- Opposite effects of a D1 and a D2 agonist on oral movements in ratsEuropean Journal of Pharmacology, 1987
- Remoxipride in schizophreniaActa Psychiatrica Scandinavica, 1986
- Antipsychotic effect of remoxipride, a new substituted benzamide with selective antidopaminergic activityActa Psychiatrica Scandinavica, 1986
- Potential neuroleptic agents. 2,6-Dialkoxybenzamide derivatives with potent dopamine receptor blocking activitiesJournal of Medicinal Chemistry, 1982
- Dopamine, acetylcholine, and GABA effects in acute dystonia in primatesPsychopharmacology, 1980
- An observational method for quantifying the behavioural effects of dopamine agonists: Contrasting effects of d-Amphetamine and apomorphinePsychopharmacology, 1980
- Pharmacological characterization of tardive dyskinesiaPsychopharmacology, 1977